BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 31206623)

  • 1. Does race predict survival for women with invasive breast cancer?
    Walsh SM; Zabor EC; Stempel M; Morrow M; Gemignani ML
    Cancer; 2019 Sep; 125(18):3139-3146. PubMed ID: 31206623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers.
    Purrington KS; Gorski D; Simon MS; Hastert TA; Kim S; Rosati R; Schwartz AG; Ratnam M
    Breast Cancer Res Treat; 2020 May; 181(1):145-154. PubMed ID: 32236827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes.
    Dawood S; Broglio K; Kau SW; Green MC; Giordano SH; Meric-Bernstam F; Buchholz TA; Albarracin C; Yang WT; Hennessy BT; Hortobagyi GN; Gonzalez-Angulo AM
    J Clin Oncol; 2009 Jan; 27(2):220-6. PubMed ID: 19047281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.
    Sheppard VB; Cavalli LR; Dash C; Kanaan YM; Dilawari AA; Horton S; Makambi KH
    Clin Breast Cancer; 2017 Jun; 17(3):232-238. PubMed ID: 28189497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparity in estrogen receptor positive breast cancer patients receiving trimodality therapy.
    Wright JL; Reis IM; Zhao W; Panoff JE; Takita C; Sujoy V; Gomez CR; Jorda M; Franceschi D; Hurley J
    Breast; 2012 Jun; 21(3):276-83. PubMed ID: 22178596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
    Sparano JA; Wang M; Zhao F; Stearns V; Martino S; Ligibel JA; Perez EA; Saphner T; Wolff AC; Sledge GW; Wood WC; Davidson NE
    J Natl Cancer Inst; 2012 Mar; 104(5):406-14. PubMed ID: 22250182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
    Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
    BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer.
    Moran MS; Yang Q; Harris LN; Jones B; Tuck DP; Haffty BG
    Cancer; 2008 Nov; 113(9):2565-74. PubMed ID: 18816610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term retrospective comparative study of the oncological outcomes of 598 very young (≤35 years) and young (36-45 years) breast cancer patients.
    Szollár A; Újhelyi M; Polgár C; Oláh E; Pukancsik D; Rubovszky G; Udvarhelyi N; Kovács T; Sávolt Á; Kenessey I; Mátrai Z
    Eur J Surg Oncol; 2019 Nov; 45(11):2009-2015. PubMed ID: 31189512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment patterns of elderly breast cancer patients at two Canadian cancer centres.
    Angarita FA; Chesney T; Elser C; Mulligan AM; McCready DR; Escallon J
    Eur J Surg Oncol; 2015 May; 41(5):625-34. PubMed ID: 25727372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race and the prognostic influence of p53 in women with breast cancer.
    Dookeran KA; Dignam JJ; Holloway N; Ferrer K; Sekosan M; McCaskill-Stevens W; Gehlert S
    Ann Surg Oncol; 2012 Jul; 19(7):2334-44. PubMed ID: 22434242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race as an independent risk factor for breast cancer survival: breast cancer outcomes from the medical college of georgia tumor registry.
    Barcenas CH; Wells J; Chong D; French J; Looney SW; Samuel TA
    Clin Breast Cancer; 2010 Feb; 10(1):59-63. PubMed ID: 20133260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol intake and invasive breast cancer risk by molecular subtype and race in the Carolina Breast Cancer Study.
    Williams LA; Olshan AF; Tse CK; Bell ME; Troester MA
    Cancer Causes Control; 2016 Feb; 27(2):259-69. PubMed ID: 26705260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
    Liu Y; West R; Weber JD; Colditz GA
    Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Black race independently predicts worse survival in uterine carcinosarcoma.
    Erickson BK; Doo DW; Zhang B; Huh WK; Leath CA
    Gynecol Oncol; 2014 May; 133(2):238-41. PubMed ID: 24613675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay.
    Barcenas CH; Raghavendra A; Sinha AK; Syed MP; Hsu L; Patangan MG; Chavez-MacGregor M; Shen Y; Hortobagyi GH; Valero V; Giordano SH; Ueno NT; Tripathy D
    Cancer; 2017 Jul; 123(13):2422-2431. PubMed ID: 28199747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
    Elledge RM; Clark GM; Chamness GC; Osborne CK
    J Natl Cancer Inst; 1994 May; 86(9):705-12. PubMed ID: 7908990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data.
    Sheppard VB; He J; Sutton A; Cromwell L; Adunlin G; Salgado TM; Tolsma D; Trout M; Robinson BE; Edmonds MC; Bosworth HB; Tadesse MG
    J Manag Care Spec Pharm; 2019 May; 25(5):578-586. PubMed ID: 31039059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer.
    Dignam JJ; Wieand K; Johnson KA; Raich P; Anderson SJ; Somkin C; Wickerham DL
    Breast Cancer Res Treat; 2006 Jun; 97(3):245-54. PubMed ID: 16331345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
    Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
    J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.